Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CorMedix (CRMD) Non Operating Income (2016 - 2025)

CorMedix's Non Operating Income history spans 12 years, with the latest figure at -$2.7 million for Q4 2025.

  • For Q4 2025, Non Operating Income fell 607.74% year-over-year to -$2.7 million; the TTM value through Dec 2025 reached -$125000.0, down 104.12%, while the annual FY2025 figure was -$125000.0, 104.12% down from the prior year.
  • Non Operating Income for Q4 2025 was -$2.7 million at CorMedix, down from $1.2 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $1.2 million in Q3 2025 and bottomed at -$2.7 million in Q4 2025.
  • The 5-year median for Non Operating Income is $449953.0 (2023), against an average of $259140.4.
  • The largest annual shift saw Non Operating Income surged 24647.35% in 2023 before it crashed 607.74% in 2025.
  • A 5-year view of Non Operating Income shows it stood at -$11066.0 in 2021, then skyrocketed by 1729.11% to $180277.0 in 2022, then surged by 301.01% to $722929.0 in 2023, then fell by 26.99% to $527797.0 in 2024, then plummeted by 607.74% to -$2.7 million in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Non Operating Income are -$2.7 million (Q4 2025), $1.2 million (Q3 2025), and $805983.0 (Q2 2025).